Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics Post author:Sam Post published:December 3, 2017 Post category:BioPharma The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace You Might Also Like Google's Verily Stumbles Amid CEO's Questionable Business Approach and Ethics Allegations April 11, 2016 Why This Connecticut Biotech Could be a $1M Opportunity for Investors January 23, 2018 <b>GDM</b> And Benson Hill Biosystems Establish Strategic Collaboration To Accelerate Soybean Breeding July 4, 2017
Google's Verily Stumbles Amid CEO's Questionable Business Approach and Ethics Allegations April 11, 2016
<b>GDM</b> And Benson Hill Biosystems Establish Strategic Collaboration To Accelerate Soybean Breeding July 4, 2017